Literature DB >> 22511433

Occult infiltrating bi-ventricular papillary renal cell carcinoma metastasis found during coronary artery bypass graft surgery.

Nathan M Mollberg1, Nicholas B Johnson, Shan-Chinga Ying, Khaled Abdelhady, Malek G Massad, Doreen E Chung.   

Abstract

Metastatic papillary renal cell carcinoma (RCC) to the heart has never been reported. We report the case of a 73-year-old patient with papillary RCC metastatic to the left and right ventricles, found during a triple vessel coronary artery bypass graft surgery.

Entities:  

Year:  2012        PMID： 22511433      PMCID： PMC3328572          DOI： 10.5489/cuaj.11144

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN： 1911-6470            Impact factor:   1.862


  12 in total

1.  Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer.

Authors:  R C Flanigan; S E Salmon; B A Blumenstein; S I Bearman; V Roy; P C McGrath; J R Caton; N Munshi; E D Crawford
Journal:  N Engl J Med       Date:  2001-12-06       Impact factor: 91.245

2.  Histologic subtype of metastatic renal cell carcinoma predicts response to combined immunochemotherapy with interleukin 2, interferon alpha and 5-fluorouracil.

Authors:  Edwin Herrmann; Olaf Anselm Brinkmann; Marc-Eric Bode; Stefan Bierer; Thomas Köpke; Martin Bögemann; Lothar Hertle; Christian Wülfing
Journal:  Eur Urol       Date:  2006-11-13       Impact factor: 20.096

3.  Metastatic renal cell carcinoma to right ventricle without vena caval involvement.

Authors:  Takuma Sato; Atsushi Takeda; Shigeyuki Yamada; Isao Numata; Kazuhiro Sakamoto
Journal:  Int J Urol       Date:  2008-04       Impact factor: 3.369

4.  Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma.

Authors:  John C Cheville; Christine M Lohse; Horst Zincke; Amy L Weaver; Michael L Blute
Journal:  Am J Surg Pathol       Date:  2003-05       Impact factor: 6.394

5.  The role of surgery in clinical management of patients with metastatic papillary renal cell carcinoma.

Authors:  Thomas Steiner; Hartmut Kirchner; Michael Siebels; Christian Doehn; Hans Heynemann; Zoltan Varga; Detlef Rohde; Joerg Schubert; Dieter Jocham; Christian Stief; Paolo Fornara; Rainer Hofmann; Stefan Loening; Jan Roigas
Journal:  J Cancer Res Clin Oncol       Date:  2009-12-12       Impact factor: 4.553

6.  Left ventricular intracavitary mass and pericarditis secondary to metastatic renal cell carcinoma--a case report.

Authors:  Arshad M Safi; Maurice Rachko; Sharon Sadeghinia; Amadeldin Zineldin; Jinwen Dong; Richard A Stein
Journal:  Angiology       Date:  2003 Jul-Aug       Impact factor: 3.619

7.  Phase II trial of carboplatin and paclitaxel in papillary renal cell carcinoma.

Authors:  Kathryn A Bylow; Michael B Atkins; Edwin M Posadas; Walter M Stadler; David F McDermott
Journal:  Clin Genitourin Cancer       Date:  2009-01       Impact factor: 2.872

8.  Efficacy of sunitinib and sorafenib in metastatic papillary and chromophobe renal cell carcinoma.

Authors:  Toni K Choueiri; Anne Plantade; Paul Elson; Sylvie Negrier; Alain Ravaud; Stephane Oudard; Ming Zhou; Brian I Rini; Ronald M Bukowski; Bernard Escudier
Journal:  J Clin Oncol       Date:  2008-01-01       Impact factor: 44.544

9.  Ventricular metastasis without atrial or caval involvement: a rare presentation.

Authors:  Ruby Satpathy; Joseph Lynch; Syed M Mohiuddin
Journal:  Echocardiography       Date:  2008-02-13       Impact factor: 1.724

10.  Effect of temsirolimus versus interferon-alpha on outcome of patients with advanced renal cell carcinoma of different tumor histologies.

Authors:  Janice P Dutcher; Paul de Souza; David McDermott; Robert A Figlin; Anna Berkenblit; Alexandra Thiele; Mizue Krygowski; Andrew Strahs; Jay Feingold; Gary Hudes
Journal:  Med Oncol       Date:  2009-02-20       Impact factor: 3.064
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.